PlantPharm BioMed Ltd. © 2018 - All rights reserved.

Therapeutic Biopharmaceutical Opportunities

Along with Infectious Disease vaccines that are the first clinically proven example of PlantPharm’s capabilities, another 500 biopharmaceutical drugs are deemed to be compatible with PlantPharm’s manufacturing platform technology thus providing a target-rich marketplace for the Company.  

Ten of the highest revenue biopharmaceuticals projected for 2020 are suitable for production in potato plants using the PlantPharm platform technology as either monoclonal antibodies or therapeutic proteins or peptides.